Madrigal Pharmaceuticals, Inc. aksje
MDGL
$481.23-16.04 (-3.23%)
Laster graf...
Madrigal Pharmaceuticals, Inc.
Market Cap
$11,095,075,840
Åpning495.74
Høy496.07
Lav479.00
Volum234k
P/EN/A
Markedsverdi11.1B
52-ukers høy615.00
52-ukers lav268.69
Gj.sn. volum315.92k
UtbytteN/A
Beta-1.04
EPS-13.47
Om Madrigal Pharmaceuticals, Inc. aksje
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Selskapsinformasjon
Børs: NasdaqGS (NMS)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Four Tower Bridge
19428 West Conshohocken, United States
19428 West Conshohocken, United States
Telefon: + 267 824 2827
Nettside: https://www.madrigalpharma.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.38 - Stærk køb
Laveste kursmål
550.00
↑ 14.3%
Gjennomsnittlig kursmål
679.29
↑ 41.2%
Median kursmål
649.50
↑ 35.0%
Høyeste kursmål
964.00
↑ 100.3%